Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.8K citations · Full text

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.8K citations · Full text

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Jean‐Frédéric Colombel, Paul Rutgeerts, Walter Reinisch et al. · Gastroenterology · 2011 · 909 citations · Full text

Inflammation, Mucosal Healing, Anti-inflammatory +10

The safety of vedolizumab for ulcerative colitis and Crohn's disease

Jean‐Frédéric Colombel, Bruce E. Sands, Paul Rutgeerts et al. · Gut · 2016 · 789 citations · Full text